NeuroMetrix, Inc. (NURO)
USD 4.42
(0.05%)
USD 4.42
(0.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -7.15 Million USD | -50.82% |
| 2022 | -4.74 Million USD | -107.55% |
| 2021 | -2.28 Million USD | -9.06% |
| 2020 | -2.09 Million USD | 81.84% |
| 2019 | -11.53 Million USD | 6.16% |
| 2018 | -12.29 Million USD | 6.05% |
| 2017 | -13.08 Million USD | 13.98% |
| 2016 | -15.2 Million USD | -14.55% |
| 2015 | -13.27 Million USD | -51.38% |
| 2014 | -8.77 Million USD | -19.18% |
| 2013 | -7.35 Million USD | 26.57% |
| 2012 | -10.02 Million USD | -0.19% |
| 2011 | -10 Million USD | 42.21% |
| 2010 | -17.3 Million USD | -148.38% |
| 2009 | -6.96 Million USD | 63.98% |
| 2008 | -19.35 Million USD | -91.03% |
| 2007 | -10.12 Million USD | -453.88% |
| 2006 | 2.86 Million USD | 1997.38% |
| 2005 | 136.47 Thousand USD | 103.86% |
| 2004 | -3.53 Million USD | 0.56% |
| 2003 | -3.55 Million USD | 26.48% |
| 2002 | -4.83 Million USD | 46.61% |
| 2001 | -9.05 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.82 Million USD | 43.8% |
| 2024 Q3 | -1.74 Million USD | 4.74% |
| 2024 Q1 | -3.25 Million USD | -75.22% |
| 2023 Q1 | -1.71 Million USD | -99.67% |
| 2023 Q2 | -1.62 Million USD | 5.06% |
| 2023 Q3 | -1.96 Million USD | -20.79% |
| 2023 FY | -7.15 Million USD | -50.82% |
| 2023 Q4 | -1.85 Million USD | 5.29% |
| 2022 Q4 | -856.46 Thousand USD | 50.0% |
| 2022 FY | -4.74 Million USD | -107.55% |
| 2022 Q1 | -961.99 Thousand USD | 4.23% |
| 2022 Q2 | -1.21 Million USD | -25.81% |
| 2022 Q3 | -1.71 Million USD | -41.53% |
| 2021 Q3 | -687.97 Thousand USD | -29.33% |
| 2021 Q4 | -1 Million USD | -46.01% |
| 2021 Q1 | -60.19 Thousand USD | 81.54% |
| 2021 Q2 | -531.96 Thousand USD | -783.73% |
| 2021 FY | -2.28 Million USD | -9.06% |
| 2020 Q3 | -257.88 Thousand USD | 69.77% |
| 2020 Q4 | -326.15 Thousand USD | -26.47% |
| 2020 FY | -2.09 Million USD | 81.84% |
| 2020 Q2 | -852.99 Thousand USD | -29.66% |
| 2020 Q1 | -657.86 Thousand USD | 60.34% |
| 2019 Q2 | -4.76 Million USD | -28.68% |
| 2019 Q3 | -1.41 Million USD | 70.35% |
| 2019 Q4 | -1.65 Million USD | -17.48% |
| 2019 FY | -11.53 Million USD | 6.16% |
| 2019 Q1 | -3.7 Million USD | -31.19% |
| 2018 FY | -12.29 Million USD | 6.05% |
| 2018 Q4 | -2.82 Million USD | -5.16% |
| 2018 Q3 | -2.68 Million USD | 15.83% |
| 2018 Q2 | -3.18 Million USD | 11.49% |
| 2018 Q1 | -3.6 Million USD | -24.85% |
| 2017 Q3 | -3.51 Million USD | -4.19% |
| 2017 Q2 | -3.37 Million USD | -1.73% |
| 2017 Q1 | -3.31 Million USD | -15.72% |
| 2017 FY | -13.08 Million USD | 13.98% |
| 2017 Q4 | -2.88 Million USD | 17.9% |
| 2016 FY | -15.2 Million USD | -14.55% |
| 2016 Q2 | -4.17 Million USD | 0.45% |
| 2016 Q3 | -3.97 Million USD | 4.96% |
| 2016 Q4 | -2.86 Million USD | 27.86% |
| 2016 Q1 | -4.19 Million USD | -26.36% |
| 2015 Q2 | -3.33 Million USD | -2.48% |
| 2015 Q1 | -3.25 Million USD | -35.43% |
| 2015 Q4 | -3.32 Million USD | 1.09% |
| 2015 FY | -13.27 Million USD | -51.38% |
| 2015 Q3 | -3.35 Million USD | -0.54% |
| 2014 Q3 | -2 Million USD | 23.48% |
| 2014 Q4 | -2.4 Million USD | -20.05% |
| 2014 FY | -8.77 Million USD | -19.18% |
| 2014 Q1 | -1.74 Million USD | -26.35% |
| 2014 Q2 | -2.61 Million USD | -50.52% |
| 2013 Q2 | -2.12 Million USD | 5.69% |
| 2013 Q1 | -2.25 Million USD | -20.24% |
| 2013 Q4 | -1.37 Million USD | 13.89% |
| 2013 FY | -7.35 Million USD | 26.57% |
| 2013 Q3 | -1.59 Million USD | 24.8% |
| 2012 Q4 | -1.87 Million USD | 28.24% |
| 2012 Q1 | -2.75 Million USD | -13.9% |
| 2012 FY | -10.02 Million USD | -0.19% |
| 2012 Q2 | -2.77 Million USD | -0.71% |
| 2012 Q3 | -2.61 Million USD | 5.85% |
| 2011 FY | -10 Million USD | 42.21% |
| 2011 Q1 | -2.7 Million USD | 39.38% |
| 2011 Q3 | -2.43 Million USD | 0.28% |
| 2011 Q4 | -2.42 Million USD | 0.64% |
| 2011 Q2 | -2.44 Million USD | 9.67% |
| 2010 FY | -17.3 Million USD | -148.38% |
| 2010 Q4 | -4.46 Million USD | -26.2% |
| 2010 Q3 | -3.53 Million USD | 21.98% |
| 2010 Q2 | -4.53 Million USD | 3.64% |
| 2010 Q1 | -4.7 Million USD | -148.55% |
| 2009 Q3 | -1.92 Million USD | -3.19% |
| 2009 FY | -6.96 Million USD | 63.98% |
| 2009 Q4 | -1.89 Million USD | 1.68% |
| 2009 Q1 | -1.28 Million USD | -146.71% |
| 2009 Q2 | -1.86 Million USD | -44.62% |
| 2008 Q2 | -3.78 Million USD | 63.87% |
| 2008 Q1 | -10.46 Million USD | -316.4% |
| 2008 FY | -19.35 Million USD | -91.03% |
| 2008 Q3 | -7.85 Million USD | -107.82% |
| 2008 Q4 | 2.75 Million USD | 135.12% |
| 2007 Q3 | -3.99 Million USD | -128.79% |
| 2007 Q2 | -1.74 Million USD | 6.56% |
| 2007 Q4 | -2.51 Million USD | 37.11% |
| 2007 FY | -10.12 Million USD | -453.88% |
| 2007 Q1 | -1.87 Million USD | -596.87% |
| 2006 FY | 2.86 Million USD | 1997.38% |
| 2006 Q1 | -138.74 Thousand USD | -123.87% |
| 2006 Q2 | 1.22 Million USD | 982.86% |
| 2006 Q4 | -268.35 Thousand USD | -113.13% |
| 2006 Q3 | 2.04 Million USD | 66.91% |
| 2005 Q2 | -224.6 Thousand USD | 70.86% |
| 2005 FY | 136.47 Thousand USD | 103.86% |
| 2005 Q4 | 581.21 Thousand USD | 5.54% |
| 2005 Q3 | 550.72 Thousand USD | 345.19% |
| 2005 Q1 | -770.85 Thousand USD | 20.97% |
| 2004 FY | -3.53 Million USD | 0.56% |
| 2004 Q4 | -975.44 Thousand USD | -28.71% |
| 2004 Q1 | -636.5 Thousand USD | 25.85% |
| 2004 Q2 | -1.16 Million USD | -82.91% |
| 2004 Q3 | -757.85 Thousand USD | 34.9% |
| 2003 Q2 | -899.98 Thousand USD | 13.48% |
| 2003 FY | -3.55 Million USD | 26.48% |
| 2003 Q4 | -858.44 Thousand USD | -13.66% |
| 2003 Q1 | -1.04 Million USD | 0.0% |
| 2003 Q3 | -755.24 Thousand USD | 16.08% |
| 2002 FY | -4.83 Million USD | 46.61% |
| 2001 FY | -9.05 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 50.202% |
| Cerus Corporation | -30.05 Million USD | 76.204% |
| OrthoPediatrics Corp. | -25.76 Million USD | 72.244% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 32.668% |
| Talis Biomedical Corporation | -66.81 Million USD | 89.297% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 58.652% |
| Inogen, Inc. | -109.38 Million USD | 93.462% |
| Spectral AI, Inc. | -12.98 Million USD | 44.921% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 88.574% |
| CVRx, Inc. | -43.1 Million USD | 83.408% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -102.708% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 42.456% |
| Orthofix Medical Inc. | -139.11 Million USD | 94.859% |
| Venus Concept Inc. | -28.3 Million USD | 74.738% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 86.763% |
| Bioventus Inc. | -81.72 Million USD | 91.249% |
| BrainsWay Ltd. | -4.92 Million USD | -45.15% |
| Envoy Medical, Inc. | -18.37 Million USD | 61.072% |
| electroCore, Inc. | -18.8 Million USD | 61.97% |
| IceCure Medical Ltd | -15.57 Million USD | 54.086% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 85.249% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 58.585% |
| MaxCyte, Inc. | -48.29 Million USD | 85.193% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 40.181% |
| Nexalin Technology, Inc. | -5.69 Million USD | -25.547% |
| PAVmed Inc | -68.79 Million USD | 89.605% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 87.357% |
| RxSight, Inc. | -50.08 Million USD | 85.721% |
| Sight Sciences, Inc. | -57.27 Million USD | 87.513% |
| SI-BONE, Inc. | -46.93 Million USD | 84.762% |
| TELA Bio, Inc. | -44.07 Million USD | 83.774% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 86.793% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 86.094% |
| LivaNova PLC | -68.49 Million USD | 89.56% |
| 908 Devices Inc. | -42.75 Million USD | 83.274% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 95.876% |
| Nemaura Medical Inc. | -9.59 Million USD | 25.468% |
| NeuroPace, Inc. | -27.17 Million USD | 73.682% |
| LENSAR, Inc. | -12.22 Million USD | 41.52% |
| Apyx Medical Corporation | -17.25 Million USD | 58.564% |
| Cutera, Inc. | -156.23 Million USD | 95.422% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 16.881% |
| BioSig Technologies, Inc. | -28.51 Million USD | 74.918% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 91.84% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 68.139% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 106.412% |
| Axonics, Inc. | -26.05 Million USD | 72.554% |
| Outset Medical, Inc. | -169.77 Million USD | 95.788% |
| IRIDEX Corporation | -10 Million USD | 28.535% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 93.449% |
| IRadimed Corporation | 20.03 Million USD | 135.694% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 13.262% |
| INVO Bioscience, Inc. | -6.76 Million USD | -5.68% |
| Telesis Bio, Inc. | -35.15 Million USD | 79.654% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 149.906% |
| Varex Imaging Corporation | 32.1 Million USD | 122.279% |
| Quipt Home Medical Corp. | 3.91 Million USD | 282.483% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 41.057% |
| Pulmonx Corporation | -61.93 Million USD | 88.453% |
| Dynatronics Corporation | -2.27 Million USD | -214.623% |
| Modular Medical, Inc. | -17.52 Million USD | 59.202% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 51.147% |
| Semler Scientific, Inc. | 22.25 Million USD | 132.133% |
| InMode Ltd. | 195.66 Million USD | 103.655% |
| Bruker Corporation | 436.9 Million USD | 101.637% |
| Cytosorbents Corporation | -31.2 Million USD | 77.085% |
| DexCom, Inc. | 597.7 Million USD | 101.197% |
| Align Technology, Inc. | 643.33 Million USD | 101.112% |
| Viveve Medical, Inc. | -21.55 Million USD | 66.819% |
| ZimVie Inc. | -30.93 Million USD | 76.885% |
| Movano Inc. | -29.69 Million USD | 75.913% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 74.317% |
| Nexalin Technology, Inc. | -5.69 Million USD | -25.547% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -102.708% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 96.934% |
| Profound Medical Corp. | -28.61 Million USD | 75.009% |
| Insulet Corporation | 220 Million USD | 103.251% |
| enVVeno Medical Corporation | -25.23 Million USD | 71.664% |
| Surmodics, Inc. | -5.64 Million USD | -26.688% |
| iCAD, Inc. | -7.68 Million USD | 6.99% |
| Nuwellis, Inc. | -17.63 Million USD | 59.436% |
| Biotricity, Inc. | -8.82 Million USD | 18.993% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 94.286% |
| Aethlon Medical, Inc. | -12.63 Million USD | 43.406% |
| InspireMD, Inc. | -21.14 Million USD | 66.175% |
| PAVmed Inc. | -68.79 Million USD | 89.605% |
| BIOLASE, Inc. | -17.93 Million USD | 60.13% |
| Beyond Air, Inc. | -63 Million USD | 88.649% |
| FONAR Corporation | 16.53 Million USD | 143.25% |
| AxoGen, Inc. | -21.46 Million USD | 66.678% |
| Vivani Medical, Inc. | -26.96 Million USD | 73.479% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 139.64% |
| Inari Medical, Inc. | -14.03 Million USD | 49.034% |
| UFP Technologies, Inc. | 57.66 Million USD | 112.402% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -45.132% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -13.412% |
| Tenon Medical, Inc. | -15.72 Million USD | 54.527% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 4.315% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 83.254% |
| AdaptHealth Corp. | -598.4 Million USD | 98.805% |
| Sintx Technologies, Inc. | -13.35 Million USD | 46.463% |
| NanoVibronix, Inc. | -3.43 Million USD | -108.135% |
| Quanterix Corporation | -49.7 Million USD | 85.611% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 41.057% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -1772.126% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.862% |
| TransMedics Group, Inc. | -28.72 Million USD | 75.105% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 69.712% |
| Hyperfine, Inc. | -48.11 Million USD | 85.137% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 89.002% |
| Biomerica, Inc. | -6.36 Million USD | -12.322% |
| Bone Biologics Corporation | -9.42 Million USD | 24.148% |
| AVITA Medical, Inc. | -40.4 Million USD | 82.299% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 30.643% |
| Silk Road Medical, Inc | -59.27 Million USD | 87.934% |